These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3838222)

  • 1. Relationship between neuroleptic malignant syndrome and malignant hyperthermia.
    Liskow BI
    Am J Psychiatry; 1985 Mar; 142(3):390. PubMed ID: 3838222
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome induced by a single injection of haloperidol.
    Konikoff F; Kuritzky A; Jerushalmi Y; Theodor E
    Br Med J (Clin Res Ed); 1984 Nov; 289(6453):1228-9. PubMed ID: 6437496
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome and malignant hyperthermia.
    Grigg JR
    Am J Psychiatry; 1988 Sep; 145(9):1175. PubMed ID: 2901237
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of malignant hyperthermia among patients with neuroleptic malignant syndrome and their families.
    Hermesh H; Aizenberg D; Lapidot M; Munitz H
    Am J Psychiatry; 1988 Nov; 145(11):1431-4. PubMed ID: 3189603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anesthetic management of a patient with neuroleptic malignant syndrome.
    Vitkun SA; Boccio RV; Poppers PJ
    J Clin Anesth; 1990; 2(3):188-91. PubMed ID: 2354060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthermic reaction to haloperidol with rigidity, associated to central core disease.
    Calore EE; Cavaliere MJ; Perez NM; Russo DH; Wakamatsu A; Razzouk D
    Acta Neurol (Napoli); 1994 Aug; 16(4):157-61. PubMed ID: 7856468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors.
    Hermesh H; Huberman M; Radvan H; Kott E
    J Nerv Ment Dis; 1984 Nov; 172(11):692-5. PubMed ID: 6238132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome.
    Martin ML; Lucid EJ; Walker RW
    Ann Emerg Med; 1985 Apr; 14(4):354-8. PubMed ID: 3985449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroleptic malignant syndrome with clozapine monotherapy and benign hyperthermia after resolving neuroleptic malignant syndrome with clozapine. Two case reports].
    Vetter P; Proppe D; Hoppe-Seyler S
    Nervenarzt; 1991 Jan; 62(1):55-7. PubMed ID: 2027422
    [No Abstract]   [Full Text] [Related]  

  • 10. [Malignant hyperthermia susceptibility in 3 patients with malignant neuroleptic syndrome].
    Silva HC; Bahia VS; Oliveira RA; Marchiori PE; Scaff M; Tsanaclis AM
    Arq Neuropsiquiatr; 2000 Sep; 58(3A):713-9. PubMed ID: 10973114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful electroconvulsive therapy in a pregnant woman with neuroleptic malignant syndrome].
    Verwiel JM; Verwey B; Heinis C; Thies JE; Bosch FH
    Ned Tijdschr Geneeskd; 1994 Jan; 138(4):196-9. PubMed ID: 8107921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myoglobinuria, malignant hyperthermia, neuroleptic malignant syndrome and serotonin syndrome.
    Bertorini TE
    Neurol Clin; 1997 Aug; 15(3):649-71. PubMed ID: 9227957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome in a trauma patient.
    Burke C; Fulda GJ; Castellano J
    J Trauma; 1995 Oct; 39(4):796-8. PubMed ID: 7473981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypomania following neuroleptic malignant syndrome.
    Steadman P
    Biol Psychiatry; 1992 Jul; 32(1):104-5. PubMed ID: 1391291
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome and the opioid system.
    Sandyk R
    Med Hypotheses; 1985 Jun; 17(2):133-7. PubMed ID: 4033475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome and malignant hyperthermia.
    Merry SN; Merry AF
    N Z Med J; 1988 Jun; 101(848):431. PubMed ID: 3393339
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome and amantadine withdrawal.
    Lazarus A
    Am J Psychiatry; 1985 Jan; 142(1):142. PubMed ID: 3966578
    [No Abstract]   [Full Text] [Related]  

  • 18. Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
    Khan A; Jaffe JH; Nelson WH; Morrison B
    J Clin Psychiatry; 1985 Jun; 46(6):244-6. PubMed ID: 3922961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
    Rock W; Elias M; Lev A; Saliba WR
    Am J Emerg Med; 2009 Oct; 27(8):1018.e1-3. PubMed ID: 19857430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome.
    Bhugra D
    Br J Psychiatry; 1984 Oct; 145():449. PubMed ID: 6487923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.